Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Leonard

Showing results (681-690 of 711) with videos related to

Pageof 72
Sort By:
Elife|March 11, 2022
Innate lymphoid cells and COVID-19 severity in SARS-CoV-2 infectionNoah J Silverstein, Yetao Wang, Zachary Manickas-Hill, et al.
International Psychogeriatrics|January 17, 2014
Development of an abbreviated version of the delirium motor subtyping scale (DMSS-4)D Meagher, D Adamis, M Leonard, et al.
The American Journal of Gastroenterology|September 29, 2025
Elevation of tTG-IgA Antibodies in a Prospective Cohort of Children at Risk of Celiac Disease: Insights From the CDGEMM CohortValentina Pucinischi, Victoria Kenyon, Monica Montuori, et al.
Journal of Medicinal Chemistry|October 28, 1997
C-terminal modifications of histidyl-N-benzylglycinamides to give improved inhibition of Ras farnesyltransferase, cellular activity, and anticancer activity in miceD J McNamara, E Dobrusin, D M Leonard, et al.
Journal of Medicinal Chemistry|January 23, 2004
Design, synthesis, and biological activity of 4-[(4-cyano-2-arylbenzyloxy)-(3-methyl-3H-imidazol-4-yl)methyl]benzonitriles as potent and selective farnesyltransferase inhibitorsLe Wang, Gary T Wang, Xilu Wang, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 18, 1999
Treatment outcome and prognostic factors for infants with acute lymphoblastic leukemia treated on two consecutive trials of the Children's Cancer GroupG H Reaman, R Sposto, M G Sensel, et al.
Bioorganic & Medicinal Chemistry Letters|July 21, 2004
Low molecular weight thrombin inhibitors with excellent potency, metabolic stability, and oral bioavailabilityMatthew M Morrissette, Kenneth J Stauffer, Peter D Williams, et al.
Scientific Reports|December 14, 2017
Cannabinoid type 2 receptors in dopamine neurons inhibits psychomotor behaviors, alters anxiety, depression and alcohol preferenceQing-Rong Liu, Ana Canseco-Alba, Hai-Ying Zhang, et al.
The American Journal of Gastroenterology|February 2, 2023
Early Antibody Dynamics in a Prospective Cohort of Children At Risk of Celiac DiseaseFrancesco Valitutti, Maureen M Leonard, Victoria Kenyon, et al.
Journal of Medicinal Chemistry|February 17, 2006
Cyclopropylamino acid amide as a pharmacophoric replacement for 2,3-diaminopyridine. Application to the design of novel bradykinin B1 receptor antagonistsMichael R Wood, Kathy M Schirripa, June J Kim, et al.
Pageof 72

Showing results (681-690 of 711) with videos related to

Sort By:
Pageof 72
Elife|March 11, 2022
Innate lymphoid cells and COVID-19 severity in SARS-CoV-2 infectionNoah J Silverstein, Yetao Wang, Zachary Manickas-Hill, et al.
International Psychogeriatrics|January 17, 2014
Development of an abbreviated version of the delirium motor subtyping scale (DMSS-4)D Meagher, D Adamis, M Leonard, et al.
The American Journal of Gastroenterology|September 29, 2025
Elevation of tTG-IgA Antibodies in a Prospective Cohort of Children at Risk of Celiac Disease: Insights From the CDGEMM CohortValentina Pucinischi, Victoria Kenyon, Monica Montuori, et al.
Journal of Medicinal Chemistry|October 28, 1997
C-terminal modifications of histidyl-N-benzylglycinamides to give improved inhibition of Ras farnesyltransferase, cellular activity, and anticancer activity in miceD J McNamara, E Dobrusin, D M Leonard, et al.
Journal of Medicinal Chemistry|January 23, 2004
Design, synthesis, and biological activity of 4-[(4-cyano-2-arylbenzyloxy)-(3-methyl-3H-imidazol-4-yl)methyl]benzonitriles as potent and selective farnesyltransferase inhibitorsLe Wang, Gary T Wang, Xilu Wang, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 18, 1999
Treatment outcome and prognostic factors for infants with acute lymphoblastic leukemia treated on two consecutive trials of the Children's Cancer GroupG H Reaman, R Sposto, M G Sensel, et al.
Bioorganic & Medicinal Chemistry Letters|July 21, 2004
Low molecular weight thrombin inhibitors with excellent potency, metabolic stability, and oral bioavailabilityMatthew M Morrissette, Kenneth J Stauffer, Peter D Williams, et al.
Scientific Reports|December 14, 2017
Cannabinoid type 2 receptors in dopamine neurons inhibits psychomotor behaviors, alters anxiety, depression and alcohol preferenceQing-Rong Liu, Ana Canseco-Alba, Hai-Ying Zhang, et al.
The American Journal of Gastroenterology|February 2, 2023
Early Antibody Dynamics in a Prospective Cohort of Children At Risk of Celiac DiseaseFrancesco Valitutti, Maureen M Leonard, Victoria Kenyon, et al.
Journal of Medicinal Chemistry|February 17, 2006
Cyclopropylamino acid amide as a pharmacophoric replacement for 2,3-diaminopyridine. Application to the design of novel bradykinin B1 receptor antagonistsMichael R Wood, Kathy M Schirripa, June J Kim, et al.
Pageof 72